2B77.DE vs. ETLI.DE
2B77.DE (iShares Ageing Population UCITS ETF) and ETLI.DE (L&G Pharma Breakthrough UCITS ETF) are both Health & Biotech Equities funds - 2B77.DE tracks the iSTOXX® FactSet Ageing Population while ETLI.DE tracks the Solactive Pharma Breakthrough Value. Both are passively managed. Over the past 5 years, 2B77.DE returned 5.15%/yr vs 2.31%/yr for ETLI.DE. A 0.71 correlation means they provide meaningful diversification when combined. 2B77.DE charges 0.40%/yr vs 0.49%/yr for ETLI.DE.
Performance
2B77.DE vs. ETLI.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B77.DE achieves a 2.83% return, which is significantly higher than ETLI.DE's -0.74% return.
2B77.DE
- 1D
- 1.81%
- 1M
- 0.31%
- YTD
- 2.83%
- 6M
- 4.39%
- 1Y
- 16.72%
- 3Y*
- 10.94%
- 5Y*
- 5.15%
- 10Y*
- —
ETLI.DE
- 1D
- 2.62%
- 1M
- -3.54%
- YTD
- -0.74%
- 6M
- -2.98%
- 1Y
- 21.87%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
2B77.DE vs. ETLI.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
2B77.DE iShares Ageing Population UCITS ETF | 2.83% | 13.27% | 14.30% | 5.16% | -8.98% | 13.25% | 2.39% | 23.81% | -9.63% |
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 17.53% | -4.78% |
Correlation
The correlation between 2B77.DE and ETLI.DE is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.69 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.70 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.72 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 2018 | 0.71 |
The correlation between 2B77.DE and ETLI.DE has been stable across timeframes, ranging from 0.69 to 0.72 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B77.DE vs. ETLI.DE — Risk / Return Rank
2B77.DE
ETLI.DE
2B77.DE vs. ETLI.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Ageing Population UCITS ETF (2B77.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B77.DE | ETLI.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.19 | ||
| Sortino ratioReturn per unit of downside risk | +0.23 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.20 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.45 | 2.40 | +0.05 |
| Martin ratioReturn relative to average drawdown | 8.32 | 6.79 | +1.52 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B77.DE | ETLI.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 1.16 | +0.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.34 | 0.13 | +0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.22 | +0.20 |
Drawdowns
2B77.DE vs. ETLI.DE - Drawdown Comparison
The maximum 2B77.DE drawdown since its inception was -38.47%, which is greater than ETLI.DE's maximum drawdown of -30.83%. Use the drawdown chart below to compare losses from any high point for 2B77.DE and ETLI.DE.
Loading charts...
Drawdown Indicators
| 2B77.DE | ETLI.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.47% | -30.83% | -7.64% |
Max Drawdown (1Y)Largest decline over 1 year | -6.80% | -9.06% | +2.26% |
Max Drawdown (3Y)Largest decline over 3 years | -20.07% | -24.43% | +4.36% |
Max Drawdown (5Y)Largest decline over 5 years | -20.07% | -30.83% | +10.76% |
Current DrawdownCurrent decline from peak | -1.60% | -4.86% | +3.26% |
Average DrawdownAverage peak-to-trough decline | -5.47% | -10.22% | +4.75% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.01% | 3.21% | -1.20% |
Volatility
2B77.DE vs. ETLI.DE - Volatility Comparison
The current volatility for iShares Ageing Population UCITS ETF (2B77.DE) is 3.36%, while L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a volatility of 6.89%. This indicates that 2B77.DE experiences smaller price fluctuations and is considered to be less risky than ETLI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B77.DE | ETLI.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.36% | 6.89% | -3.53% |
Volatility (6M)Calculated over the trailing 6-month period | 9.17% | 14.09% | -4.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 12.28% | 18.72% | -6.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.09% | 17.22% | -2.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.52% | 18.91% | -2.39% |
2B77.DE vs. ETLI.DE - Expense Ratio Comparison
2B77.DE has a 0.40% expense ratio, which is lower than ETLI.DE's 0.49% expense ratio.
Dividends
2B77.DE vs. ETLI.DE - Dividend Comparison
Neither 2B77.DE nor ETLI.DE has paid dividends to shareholders.
Frequently Asked Questions
2B77.DE and ETLI.DE have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B77.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B77.DE is cheaper with a 0.40% expense ratio, compared with 0.49% for ETLI.DE.
2B77.DE tracks iSTOXX® FactSet Ageing Population, while ETLI.DE tracks Solactive Pharma Breakthrough Value. They also come from different issuers: iShares and Legal & General. Their fees differ too: 0.40% for 2B77.DE and 0.49% for ETLI.DE.
Find the right allocation for 2B77.DE and ETLI.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer